Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation

NCT01326273 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

CMV Reactivation
Allogeneic Stem Cell Transplantation
Autologous CMV Specific CD8+ T Cells

Interventions

PROCEDURE: Lymphopheresis
PROCEDURE: CMV specific lymphocyte infusion
PROCEDURE: Peripheral blood for CMV DNA PCR
PROCEDURE: Haematology/Blood chemistry

Sponsor

Imperial College London